Prodrugs of fumarates and their use in treating various diseases Grant US-11905298-B2 United States of America 20 Feb 2024
Dosage regimen of an S1P receptor modulator Grant US-11759436-B2 United States of America 19 Sep 2023
Prodrugs of fumarates and their use in treating various diseases Grant US-11679092-B2 United States of America 20 Jun 2023
Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators Grant US-11484530-B2 United States of America 01 Nov 2022
Prodrugs of fumarates and their use in treating various diseases Grant US-11230548-B2 United States of America 25 Jan 2022
Prodrugs of fumarates and their use in treating various diseases Grant US-11083703-B2 United States of America 10 Aug 2021
Prodrugs of fumarates and their use in treating various diseases Grant US-10596140-B2 United States of America 24 Mar 2020
Dosage regimen of an S1P receptor modulator Grant US-10543179-B2 United States of America 28 Jan 2020
LINGO-1 antagonists and uses for treatment of demyelinating disorders Grant US-10435467-B2 United States of America 08 Oct 2019
Pharmaceutical compositions comprising glitazones and NRF2 activators Grant US-10426763-B2 United States of America 01 Oct 2019
Prodrugs of fumarates and their use in treating various diseases Grant US-10406133-B2 United States of America 10 Sep 2019
COMPOSITION FOR TREATING MULTIPLE SCLEROSIS Application EA-028308-B1 Eurasian Patent Organisation 30 Nov 2017
Cognitive composite parameters and uses thereof for evaluating multiple sclerosis Grant US-9717453-B2 United States of America 01 Aug 2017
Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various… Grant US-9604922-B2 United States of America 28 Mar 2017
Prodrugs of fumarates and their use in treating various diseases Grant US-9505776-B2 United States of America 29 Nov 2016
Prodrugs of fumarates and their use in treating various diseases Grant US-9090558-B2 United States of America 28 Jul 2015
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE Application EP-2736335-A4 European Patent Office 07 Jan 2015
Treatment of multiple sclerosis with combination of laquinimod and fingolimod Grant US-8889627-B2 United States of America 18 Nov 2014
TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND GLATIRAMER ACETATE Application EP-2736335-A1 European Patent Office 04 Jun 2014
Prodrugs of fumarates and their use in treating various diseases Grant US-8669281-B1 United States of America 11 Mar 2014
COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VARIANTS) Application WO-2013184023-A1 World Intellectual Property Organisation (WIPO) 12 Dec 2013
Treatment Of Multiple Sclerosis With Combination Of Laquinimod And Fingolimod Application US-20130096158-A1 United States of America 18 Apr 2013